NIH PAR · NIAMS · R03
PAR-27-074: Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) announces a program that provides NIAMS-supported K01, K08, K23, and K25 recipients the opportunity to apply for the Small Grant (R03) during the second to fourth year of their K award, as well as to provide support to recipients of significant career development awards from federal or non-federal organizations that are focused on the NIAMS' mission areas. Through this mechanism, which allows up to $50,000 direct costs per year for up to two years, the NIAMS is seeking to enhance the capability of scientists to conduct research as they transition to fully independent investigator. The R03 grant mechanism…
- NOFO number
- PAR-27-074
- Type
- PAR
- Activity code
- R03
- Primary institute
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Clinical trials
- Not Allowed
- Posted
- May 28, 2026
- Opens
- Sep 16, 2026
- Expires
- Jul 17, 2029
PAR-27-074 due dates
9 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| October 16, 2026 * | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 * | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 * | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 * | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
| February 16, 2028 * | March 16, 2028 * | Not Applicable | July 2028 | October 2028 | December 2028 |
| June 16, 2028 * | July 16, 2028 * | Not Applicable | November 2028 | January 2029 | April 2029 |
| October 16, 2028 * | November 16, 2028 * | Not Applicable | March 2029 | May 2029 | July 2029 |
| February 16, 2029 * | March 16, 2029 * | Not Applicable | July 2029 | October 2029 | December 2029 |
| June 16, 2029 * | July 16, 2029 * | Not Applicable | November 2029 | January 2030 | April 2030 |
What its predecessor PAR-24-287 funded
PAR-27-074 reissues PAR-24-287. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 2 projects and $308K in FY2022–FY2026.
Projects funded
2
Distinct projects, FY2022–FY2026
New awards
2
Type 1 (new project) award records
NIH funding
$308K
Award dollars under PAR-24-287, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 2 | 2 | $308K |
Institutions with the most funding
- University of Texas Hlth Sci Ctr Houston$156K · 1 project
- Brigham and Women's Hospital$152K · 1 project
Funding institutes
- NIAMS$308K · 2
Activity codes funded
- R032 records
Most recent new awards
- Modifying bone morphogenetic protein 9 (BMP9) signaling in secondary lymphedema (opens NIH RePORTER)
Brigham and Women's Hospital · 1R03AR086904-01 · NIAMS · Notice Jul 20, 2026
$152KR03
- Pulmonary arterial hypertension susceptibility in systemic sclerosis patients with the DNASE1L3 R206C variant (opens NIH RePORTER)
University of Texas Hlth Sci Ctr Houston · 1R03AR086931-01 · NIAMS · Notice Jun 19, 2026
$156KR03
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-27-074. Contact the program officer at the institute that fits your research before applying.
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- none
Related notices
NIH lists no related notices for PAR-27-074 yet.
Award terms
- Application types allowed
- New Resubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Up to 100,000 in direct costs will be awarded for the two-year project period. Award budget must reflect the actual needs of the proposed project.
- Project period
- Awards are multi-year funded with all funds disbursed in the first year of the award. Application budgets are limited to 50,000 direct costs per year, for each of two years. NIAMS encourages R03 funds to be used primarily for research support costs, including salary of a research associate/technician. NIH grants policies as described in the NIH Grants Policy Statement will apply to the…
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-24-287.
Other open NOFOs for R03
- PAS-27-028Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)NIDA · next due Oct 16, 2026
- PAR-25-370Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NHGRI · next due Oct 16, 2026
- PAR-25-091Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)NIDDK · next due Oct 16, 2026
- PA-25-302NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)NIH · next due Oct 16, 2026
- PA-25-125NICHD Small Research Grant Program (R03 Clinical Trial Required)NICHD · next due Oct 16, 2026
- PAR-25-105NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)NIDCR · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.